i‘SUPPLY, Egyptian B2B Pharma Platform Completes $1.5m Pre-seed Funding Round

B2B pharmaceutical platform i’SUPPLY, based in Egypt, has secured US$1.5 million in a pre-seed round to expand throughout the Middle East and Africa.

Ibrahim Emam, Malek Sultan, and Moustafa Zaki founded i’SUPPLY in 2021 with the goal of digitising the pharmaceutical industry by offering a one-stop-shop solution to promptly anticipate and deal with supply chain problems.

i’SUPPLY, which will make its debut late in 2021, “aims to alter the wholesale distribution of medicines in the MENA area and Africa by focusing on supporting and empowering the mid and small-sized wholesalers and pharmacies,” according to Emam.

“The company is constructing a trustworthy and integrated network that enhances and augments traditional brick and mortar platforms with data-driven disruptive sales, distribution, and procurement solutions that optimize the procurement processes and provide a one-stop-shop solution that supports industry’s stakeholders to quickly predict and overcome supply chain disruptions,” according to the company.

Pre-seed funding for i’SUPPLY totaled US$1.5 million, with Disruptech Ventures serving as the round’s lead investor. The firm has had rapid development since its introduction, adding 5,000 pharmacies and producing more than 50,000 sales. It now plans to grow throughout Egypt, aiming to reach 60,000 shops. In addition to establishing distribution and finance services, i’SUPPLY intends to grow throughout Africa and the MENA area.

“The team at Disruptech is thrilled to be a part of iSupply’s development; we always support and stand by great founders like Ibrahim and the members of i’SUPPLY. Malek Sultan, co-founder and partner at Disruptech, expressed his optimism that Ibrahim and his team will bring about genuine, constructive disruption in the market.